Background. Zatebradine (UL-FS 49) is a drug with a specific bradycardiac electrophysiological profile. It reduces heart rate by lengthening the duration of diastolic depolarization in the sinoatrial (SA) node. The ionic basis of this action, however, is not clarified.
currently available drugs for the treatment of ischemic heart disease. (Cruation. 1993; 88[part 11:2389 -2401 KEY WORDs * bradycardia * heart rate * ischemia * ion channels In the treatment of ischemic heart disease, P-blockers have a well-established position. Heart rate reduction seems to be an important element in the anti-ischemic action of these drugs."2 Heart rate reduction by (3- blockers is partially caused by a block of the stimulating effect of catecholamines on the hyperpolarization activated current If (or Ih) in the sinoatrial (SA) node.3-7 Since (3-blockers also have negative inotropic and dromotropic effects that can reduce their usefulness and applicability in ischemic heart disease, drugs targeted at the pacemaker current If can possibly be superior in certain aspects.8 '9 Zatebradine (UL-FS 49) is a drug with a specific bradycardiac effect.10-13 It reduces heart rate in a frequency-dependent manner with little or no effect on inotropism, both in animal models'0-22 and in humans. [23] [24] [25] [26] [27] [28] The substance reduces the increase in heart rate caused by (3-stimulation in a noncompetitive manner, without influencing the positive inotropic effect.'3'29 Heart rate reduction is caused by a direct effect on diastolic depolarization rate (DDR) (phase IV) of the SA node action potential. [30] [31] [32] The molecular mode of action of zatebradine, however, is still unclear.33 '34 In sheep cardiac Purkinje fibers, we demonstrated that low concentrations of zatebradine block the pacemaker current If in a use-dependent manner. [35] [36] [37] Since a highly similar current is involved in physiological pacemaking of SA tissue,6,38 we investigated the effects of zatebradine on this current in isolated rabbit SA node cells. The effects of the drug on two other currents that also play a role in normal pacemaking of the SA node were studied as well: the L-type calcium current, ICaL, and the delayed rectifier potassium current, IK. [38] [39] [40] Our data demonstrate that zatebradine blocks the pacemaker current If in a use-dependent manner at low concentrations with minimal effects on ICaL and IK. This block of If can explain the observed specific bradycardiac profile of this substance. Zatebradine, therefore, belongs to a new class of cardiac drugs that act primarily via use-dependent blockade of If. Preliminary results have been published in abstract form.4'
Methods

SA Node Cell Isolation
New Zealand White rabbits of either sex, weighing 1.5 to 2.5 kg, were killed by cervical dislocation, after which the heart was quickly removed. The SA node was dissected out in oxygenated normal Tyrode's solution at room temperature. Approximately five small strips (+2x 1 mm) were cut perpendicular to the crista terminalis and placed in a Ca`4-free Tyrode's solution at room temperature for 5 minutes. The strips were then incubated in a Ca`4-free, Mg 2+-enriched Tyrode's solution containing 1 mg/mL bovine serum albumin (Sig-ma), 0.29 U/mL collagenase B (Boehringer Mannheim), and 12 U/mL elastase (Serva) at 37°C. The strips were gently drawn up and down through a glass pipette (tip diameter of 2 mm) by a digital linear actuator (Airpax, K92141-P2) attached to a 10-mL glass syringe, thus allowing visualization of the extent of digestion. After 13 to 15 minutes, the strips were washed in a high-K', low-Ca2+ solution. They were then more aggressively agitated up and down through a glass pipette with a tip diameter of 1.6 mm to allow mechanical dissociation of the cells in the high-K', low-Ca21 solution (at 37°C).
Five minutes later, the strips were removed and the isolated cells allowed to recover in this solution for at least 30 minutes at room temperature. Cells were used for electrophysiological study within 8 hours.
Electrophysiological Recording
For recording at room temperature, cells were held in a small Petri dish. The dish volume was reduced to 0.6 mL by insertion of a Teflon ring. Another chamber (Plexiglas; volume, 0.4 mL) was used for containing cells while recording at higher temperatures. The recording chamber was mounted on the stage of an inverted microscope (Nikon Diaphot). The cells, suspended in the high-K+, low-Ca2+ solution, were transferred to the recording chamber approximately 30 minutes before the start of the study. Once the cells had settled to the bottom, they were superfused with normal Tyrode's solution (20 to 24°C; flow rate, ±+1.5 mUmin). Heating was achieved in some experiments with a heating plate in close contact with the bottom of the recording chamber, as described by van Ginneken and Giles42 (kindly provided by the workshop of the University of Amsterdam). Bath temperature was continuously monitored.
The recording chamber contained a Ag-AgCl electrode connected to the HS-2L headstage (gain, 0.1) of the Axoclamp-2A current-and voltage-clamp amplifier and Labmaster TL-1 DMA interface (Axon Instruments). Membrane potentials and currents were recorded with the whole-cell variant of the patch-clamp technique.43 Electrodes were pulled from 2 mm outside diameter glass capillaries (Jencons, H15/10) with a P-87 Brown-Flaming horizontal micropipette puller (Sutter Instrument Co) and heat-polished. They were filled by dipping in an internal pipette solution (filtered through a micropore filter) combined with backfilling. Mainly spontaneously contracting, spindle-shaped SA node cells44 were used (length, ±40 to 100 jgtm; width, ±6 to 10 ,um; capacitance, 52±14 pF [N=46]: data were not corrected for stray capacitance). The patch electrode (resistance between 2 and 4 MfQ) was positioned on the cell with a micromanipulator (Narishige, WR-88-R). Before the pipette was attached, cells were made quiescent by either 1 mmol/L Ni2+ or 0.2 ,mol/L acetylcholine. Gigaohm seal formation (>10 GQ) was monitored on a digital oscilloscope (Hewlett Packard, 54601A). The membrane was ruptured by short suction with a 1-mL syringe connected by flexible tubing to the patch pipette holder. Recording was started after 5 minutes of dialysis of the cell and washout of Ni2+ or acetylcholine. To reduce series resistance problems, single-electrode voltage-clamp was performed in discontinuous mode at a sampling rate of 5 kHz for measurement of I and LK and of 10 to 15 kHz for sample-and-hold circuit was continuously monitored to ensure complete settling between current injection cycles. No capacitance correction was used. Rundown of If was significant in the first minutes after membrane rupture before the experiments were started. It then slowed (as demonstrated by the small reduction of If after 7 minutes of perfusion with the drug [Fig 1] , the large extent of unblock [Fig 4] , and the recovery of a significant fraction of If on washout and hyperpolarization [Fig 8] ) and therefore did not disturb measurements of use-dependent block. Effects on ICaL and IK were usually studied within 20 minutes after rupture of the membrane, thereby limiting problems of potential rundown.
Solutions and Drugs
Normal Tyrode's solution contained (in mmol/L): NaCl 140, KCl 5.4, CaCl2 1.8, MgCl2 0.5, glucose 10, HEPES 5; pH adjusted to 7.4 with 1 mol/L NaOH. Ca2+-free Tyrode's solution was made by omitting CaCl2. Ca2+-free, Mg 2+-enriched Tyrode's solution was made by omitting CaCl2 and adding MgCl2 to a total concentration of 3.5 mmol/L. The high-K', low-Ca21 solution contained (in mmol/L): KCl 40, KOH 70, KH2PO4 20, MgCl2 3, L-glutamic acid 50, taurine 20, EGTA 0.5, Na2ATP 2, HEPES 10, glucose 10; pH was adjusted to 7.4 with KOH. The internal pipette solution contained (in mmol/ L): KCl 20 , aspartic acid 110, KOH 110, CaCI2 0.5, EGTA 3, MgATP 5, di-tris phosphocreatine 2.5, di-Na+ phosphocreatine 2.5, cAMP 0.05, HEPES 5; pH was adjusted to 7.4 with 1 mol/L KOH. NiCI2 and acetylcholine were added to the Tyrode's solution from 1 mol/L and 1 mmol/L stock solutions, respectively. Zatebradine (UL-FS 49 Cl, or 1,3,4,5-tetrahydro-7,8-dimethoxy-3-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylimino]propyl]-2H-3-benzazepin-2-on-hydrochloride) was kindly supplied by Dr Karl Thomae GmbH, Biberach, FRG. The drug was added to the Tyrode's solution from a stock solution (10-2 or 10-3 mol/L) in H20. CsCl was added to the Tyrode's solution in some experiments from a 1 mol/L stock solution (final concentration, 2 mmol/L).
Data Collection and Analysis
Voltage-clamp step commands were given with an IBM-compatible PC/AT with pClamp 5.6 software (Axon Instruments). Data were additionally filtered when necessary with a Butterworth filter (Kemo, VBF 803), on-line digitized (sample frequency, +5 kHz for ICaL, ±300 Hz for If and IK measurement), and stored on hard disk. Spontaneous electrical activity was recorded in bridge mode (sample frequency S kHz) and stored on hard disk with Axotape 1.2.01 software (Axon Instruments). pClamp, Lotus 123, and SigmaPlot 4.1 (Jandel Corp) software was used for subsequent analysis. Nonlinear curve fitting was performed with the Marquardt-Levenberg algorithm of SigmaPlot 4.1. The liquid junction potential between the pipette solution and normal Tyrode's solution was +8 mV, for which data were corrected. Currents were normalized to cell capacitance. Data are given as mean values±SD. Paired measurement of ICaL (30% duty cycle). The input of the Student's t tests were performed where appropriate.
Results
Zatebradine Reduces Spontaneous Pacing Rate
Mainly by Reducing Diastolic Depolarization Rate
In the whole SA node preparation, it has been demonstrated that the heart rate reduction by zatebradine is caused by a reduction of DDR. [30] [31] [32] Similar results were obtained in spontaneously active isolated SA node cells. Perfusion with zatebradine (10-6 mol/L) for 15 minutes caused a reduction of spontaneous pacing rate (SPR) and DDR by 16±8% and 36±12%, respectively (n=3; temperature, ±330C). A variable increase of action potential duration at 90% of repolarization (APDgo) was observed (12±15% [n=3]). Upstroke velocity was not significantly altered.
Zatebradine Blocks the Pacemaker Current If in a
Use-Dependent Manner
The pacemaker current If is blocked in a use-dependent manner by low concentrations of zatebradine in sheep cardiac Purkinje fibers (apparent Kd=6x 10-8 mol/L). [35] [36] [37] Since this ionic current has a key role in the generation of diastolic depolarization of the SA node,6,38 the blockade characteristics of If by zatebradine were studied in isolated rabbit SA node cells using voltage-clamp pulse trains. A representative example is shown in Fig 1 ( protocol as in panel A, inset). On hyperpolarization of the cell membrane from 0 to -100 mV, a large slowly increasing inward current was seen ( Fig 1A, " Control"). This current is caused by the pacemaker current If activating on hyperpolarization of the cell membrane (see Fig 1B, inset: "If").5-7,42 After 1 second, the membrane was depolarized back to 0 mV, which caused an outward tail current preceded by a short inward current. The outward tail current is caused by the deactivation of If.7 In normal Tyrode's solution, the voltage-clamp pulse train between 0 and -100 mV (at 0.5 Hz) caused no major changes in the current amplitude during consecutive steps ( Fig 1B, "Control"; longer control runs were applied in other cells). Membrane potential was then clamped at -20 mV, at which most If channels are expected to be closed,7 and perfusion with 5x 10-7 mol/L zatebradine was started. No change in holding current occurred at this membrane potential. After 7 minutes of perfusion with the drug, the voltage-clamp pulse train was restarted from 0 mV. No major changes were observed in the small instantaneous current jump ( Fig 1B, Fig 3B. A straight line is drawn through data points at which If is fully activated. The intercept of the two lines coincides with the estimated reversal potential of If7 which indicates that the difference in steady-state current is indeed caused by block of If. The reduction in slope of the line is consistent with a reduction of the fully activated If conductance. An estimation of the If conductance could also be obtained by comparing the tail currents at -45 mV.
Maximal If conductance, gf,, as determined by the maximal tail current amplitude, was reduced by a similar amount as the time-dependent current on hyperpolarization. An activation curve for If was obtained by normalizing the tail current amplitude to the maximal tail current (ie, normalized conductance or gf/gf,). This activation curve is shown in Fig 3C for six cells before (open symbols) and after (closed symbols) partial block of If. No major shift of the activation curve was observed.
The current traces during small hyperpolarizing voltage-clamp steps could be fitted well with a single exponential equation. Usually a double exponential fit was necessary at potentials beyond -80 mV. A progressive slowing of time constants is observed in normal Tyrode's solution and complicates study of the effect of zatebradine on kinetics. The single exponential time constant, r, at modest hyperpolarization increased slightly after partial block of If, eg, by 24+21% (n=5) at Block could then be reinduced with a pulse train and the unblocking procedure repeated at -70 and -100 mV. Very little unblock was seen after 100 seconds at -70 mV, whereas almost 70% of control If was recovered after 30 seconds at -100 mV ( Fig 4B) . The fraction of control If recovered is shown as a function of membrane potential for six more cells in panel C. At hyperpolarized potentials, more than 90% of control If could be recovered in three cells.
Zatebradine (106 moliL) Has Little Effect on the L-Type Ca2+ Current
Since the L-type Ca21 current provides some inward current during diastolic depolarization of the SA node,40 the effects of zatebradine on this Ca21 current were explored. Voltage-clamp pulses were given in normal Tyrode's solution from a holding potential of -40 mV to depolarized levels (Figs 5A and SB). No changes are observed in the current traces after perfusion with 10-6 mol/L zatebradine ( Fig SA) . Average normalized peak minus steady-state current (which is a good approximation of the amplitude of ICa L47) of seven cells showed no significant changes either ( Fig SB) .
We also explored the possibility of use-dependent block of CaL at the same stimulation frequency as was used to illustrate use-dependent block of If (see Fig 1) .
Zatebradine 10-6 mol/L caused no significant use-dependent block of ICaL when a voltage-clamp pulse train was applied between -50 and +10 mV at 0.5 Hz (averages of six cells are shown in Fig 5C; longer pulse trains [N=75] were applied in three cells with similar results). Zatebradine (106 moliL) Causes a Small Block of the Delayed Rectifier K+ Current
The delayed rectifier potassium current IK deactivates during diastolic depolarization of the SA node. 38, 48 The effects of zatebradine on IK were studied by applying depolarizing voltage-clamp pulses of 750 milliseconds from -45 mV to activate the current ( Fig 6A) . On repolarization back to -45 mV, an outward IK tail current was seen. After perfusion with 10-6 mol/L zatebradine, the outward current during depolarization to 36 mV and the tail current on repolarization to -45 mV decreased by 19% and 21%, respectively, in this cell. Average normalized current at the end of the depolarizing steps is demonstrated in Fig 6B. Average steady-state current at +30 mV was reduced by 8±9% (P>.05; n=10). Maximal tail current at -45 mV was reduced by 18+8% (P< .05; n= 10). These changes were partially reversible after 10 minutes of washout in three cells.
When a voltage-clamp pulse train was applied from -45 to +20 mV (for 750 milliseconds) at 0.5 Hz, no use-dependent block could be observed with 10-6 mol/L zatebradine (n=2; temperature, 33°C). Average steadystate current during depolarization was reduced by 23% and 6% in the two cells, respectively. Zatebradine (10-6 moliL) Effectively Blocks If With Minimal Effect on IcaL and IK Additional data demonstrating the selectivity of low concentrations of zatebradine for If were obtained by applying a different voltage-clamp pulse train (Fig 7, protocol, see inset panel A; temperature, 320C). This protocol allowed simultaneous investigation of the effect of the drug on ICaL, IK, and If (Fig 7A, Control, and inset Fig 7B) . On depolarization to 5 mV from -40 mV, a short inward current (ie, mainly Ic L") was followed by a slowly increasing outward current (ie, mainly IK47). Hyperpolarization to -90 mV subsequently caused a gradually increasing inward current (ie, If). On repolarization to -40 mV, a short inward current was followed by a progressively decreasing inward If tail current. In a control pulse train, IK slowly increased to a steady-state level (current amplitude of every fifth pulse is plotted in Fig 7B) . Except for a small initial decrease, CaL and If showed no major changes during the consecutive steps of the control pulse train.
Reapplication of the pulse train after 7 minutes of perfusion with 106 mol/L zatebradine at -20 mV caused no reduction of ICaL (+5.1%), whereas a clear exponential reduction of If was seen (96.2%). The outward current at the end of the 500-millisecond depolarization to +5 mV decreased by 28%. In another cell, 10-6 mol/L zatebradine reduced ICaL by 7%, If by 91%, and IK by 18%. The pulse constant for If reduction was 40 pulses (temperature, 340C).
Zatebradine Reduces Spontaneous Pacing Rate in Parallel With If Amplitude
In SA node cells, DDR and SPR varied synchronously with If amplitude (Fig 8) . When If had been almost completely blocked with 5 x 106 mol/L zatebradine, by applying a voltage-clamp pulse train, DDR was decreased (compare Figs 8A and 8B ). This high concentration of the drug also caused an increase in APD and a decrease of maximal diastolic potential, consistent with block of 'K. After 15 minutes of washout of the drug, APD90 and maximum diastolic potential were almost normalized, whereas DDR and If amplitude had only slightly increased ( Fig 8C) . Recovery of If and DDR could be achieved much faster by prolonged hyperpolarization of the membrane potential ( Fig 8D) . An increase of pacing rate was observed after this procedure as well. Reapplication of 106 mol/L zatebradine afterward, during spontaneous activity, again caused a decrease in DDR and SPR as well as reduction of If (Fig 8E) . In spontaneously active cells, If amplitude decreased by 47+8% after 15 minutes of perfusion with 106 mol/L zatebradine (n=3). 
Sinus Node Inhibitors Reduce Diastolic
Depolarization Rate and If
The sinus node inhibitor (or "specific bradycardic agent") zatebradine reduces heart rate with minimal effects on myocardial contractility and atrioventricular conduction characteristics.10-2949 The heart rate reduction is caused primarily by a direct effect on DDR in the SA node. [30] [31] [32] In sheep cardiac Purkinje fibers, we demonstrated that zatebradine and similar drugs reduce the hyperpolarization-activated current If.35-37'50 These drugs can be subdivided into two classes on the basis of their mode of interaction with the If channel. Alinidine and derivatives primarily shift the activation curve of If to more hyperpolarized potentials (and cause a tonic block of If at high concentrations),35,50 whereas zatebradine and related compounds cause a use-dependent block of If without shifting the activation curve. [35] [36] [37] In the isolated SA node cell, a reduction of DDR was also mainly responsible for the reduction of SPR by Peak minus steady-state current, (ip,,k-i,), of six cells was normalized for every step of the pulse train. Current amplitude was scaled to the average current of the first control step and zatebradine. The amplitude of If decreased simultaneously with DDR when the drug was applied to these cells (Fig 8) . The observed block of If by zatebradine during spontaneous activity is additional proof that the channel is used during the normal action potential cycle, since If block by the drug is use dependent. The increase in heart rate caused by an increase in DDR after recovery of If (Fig 8D versus 8C) demonstrates its role in diastolic depolarization.
Role of If in
Use-Dependent Block of If by Zatebradine
Use-dependent or phasic block of voltage-gated ion channels is a well-known phenomenon.57 It can be plotted as mean ±SD for the consecutive steps (pulse number, N) of the train (control, o; zatebradine, *). explained by different affinities of various conformational states of the channel for a drug or by an only transiently accessible binding site on the channel, with a constant affinity.58'59 Receptor affinity for a drug can also be modulated by membrane potential and ionic current passing through the channel. When the conformation of a channel alters between its different states, as during action potentials or during a voltage-clamp pulse train, block of the channel can accumulate depending on the relative time spent in the various states at different potentials. This mode of action has been described for many clinically used cardiac drugs. 58-6' The pacemaker current If in cardiac Purkinje fibers is blocked in a use-dependent manner by low concentrations of zatebradine. [35] [36] [37] The drug reaches its receptor, which is probably located inside the pore of the channel, from the cytosolic surface of the cell membrane.36'37'62 Similar use-dependent block of If is observed in isolated SA node cells (Figs 1 and 7) . As in the Purkinje fibers, no significant block of If seems to occur when the channels are closed. The small reduction of If at the first step of the voltage-clamp pulse train, after 7 minutes of perfusion with the drug, did not vary with drug concentration and is probably a result of gradual rundown of the current. The reduction of If is not caused by a shift of its activation range but rather by a reduction of the fully activated If conductance (Fig 3) . No major shift of the reversal potential seems to occur.
The apparent Kd obtained with the application of voltage-clamp pulse trains is different from a Kd obtained in equilibrium conditions but will be more relevant to the clinical situation, in which membrane potential continuously alternates between different values. This apparent Kd for use-dependent If block in the SA node depends on the stimulation protocol used. The unblock occurring at hyperpolarized membrane potentials (Fig 4) limits steady-state use-dependent block obtained with the protocol shown in Fig 1. Indeed, when a voltage-clamp pulse train with a shortened hyperpolarizing pulse duration was applied, steady-state If block increased. The reduced number of channels opening during every hyperpolarizing pulse with this protocol, however, decreased the rate of block. Consistent with some unblock occurring at hyperpolarized potentials during the voltage-clamp pulse train is also the somewhat faster decline of the peak outward If tail current compared with the reduction of the inward If on hyperpolarization. Because of overlap of the If tail current with other activating and inactivating currents (ICaL, ICaT, and IK), further analysis of tail current kinetics is impossible, based on our results.
At a higher stimulation frequency, the block of If by zatebradine will be more effective. This has been observed in cardiac Purkinje fibers, in which it explains the observed frequency dependence of the reduction of DDR. 36 In this preparation, the apparent Kd for DDR reduction (9x108 mol/L) and for If block (8x 108 mol/L) at a higher pulse frequency (0.8 Hz) are in the same range as the EC50 for heart rate reduction in animal experiments (+ 10`mol/L)10 and as the concen- 
Zatebradine Selectively Blocks If at Clinically
Relevant Concentrations
No significant tonic or use-dependent block of the L-type calcium current was observed (Figs 5 and 7) at a concentration of zatebradine (10-6 mol/L) and a stimulation frequency (0.5 Hz) causing major use-dependent block of If (65% to 95%). Consistent with these results, significant use-dependent block of ICaL was observed only in ventricular myocytes at higher drug concentrations (apparent Kd.5x 10-6 mol/L) and at high stimulation rates (0.8 Hz).64 Voltage-dependent ICaL unblock at the hyperpolarized resting potential prevents significant block of this calcium current in these cells. When stimulation was performed with a high pulse frequency (3.3 Hz) from a more depolarized membrane potential (-40 mV) in isolated rabbit SA node cells, only 23% reduction of ICaL by 10-6 mol/L zatebradine was observed by other investigators.65 These investigators did not observe significant block of If in rabbit and guinea pig SA node cells by zatebradine at concentrations <10-6 mol/L. They did not, however, investigate the possibility of use-dependent block of If. Data on usedependent block of ICa,L (at the fast stimulation rate from depolarized potentials, without correction for rundown) were compared with data on tonic blockade of If. The absence of significant tonic blockade of If is, indeed, consistent with our data. The amplitude of If observed in the cells illustrated in their paper65 is also much smaller than that obtained in our SA node cells, which can limit the detection of If blockade. The smaller If is probably caused by a different, more damaging enzymatic isolation procedure used by these authors.
Species differences are known to exist for the bradycardiac effect of zatebradine.34 In guinea pig SA node, the bradycardiac effect of zatebradine is more pronounced than in rabbit. In isolated guinea pig SA node cells, however, zatebradine seems to block both ICaL and If more effectively than in rabbit.65166 No complete investigation of the effect of zatebradine on If has, as yet, been done in guinea pig SA node cells.
Action potential data are compatible with the absence of significant calcium current block by low concentrations lC Control + 1 0 M zatet of this molecule. In our isolated SA node cells and in the whole SA node preparations,30'32 no significant effect of the drug was observed on action potential upstroke velocity or action potential amplitude. Many pharmacological results also indicate a clear difference in the mode of action of calcium antagonists and sinus node inhibitors like zatebradine.12,3449 (1) In SA node preparations, depolarized in high potassium, calcium antagonists have an increased effectiveness. Sinus node inhibitors, on the other hand, are less effective in these circumstances. 13 (2) After maximal bradycardia is achieved with a sinus node inhibitor, calcium antagonists can still cause additional bradycardia.33 (3) Calcium antagonists are also much more potent than sinus node inhibitors for reducing the rate of barium-induced spontaneous atrial activity.67 They are less effective if calcium concentration is lowered.33 (4) Standstill of SA node preparations can occur with bradycardiac concentrations of calcium antagonists but is not observed at even maximal bradycardiac concentrations of sinus node inhibitors." These pharmacological results cannot be explained by the observation that unblock of ICaL occurs at less hyperpolarized membrane potentials compared with classical calcium antagonists, as has been proposed. 65 The T-type calcium current ICaT provides inward current during the terminal phase of diastolic depolar- ization of the SA node.68 In ventricular myocytes, it has been demonstrated that this calcium current is even less sensitive to zatebradine than the L-type calcium current. 64 Thus, at the low concentrations used in animal and clinical studies (10-8 to 10-7 mol/L), neither ICaL nor ICa,T block seems to play an important role in the mechanism of heart rate reduction by zatebradine. In rabbit SA node cells, the delayed rectifier potassium current is composed mainly of the E4031-sensitive rapidly activating type, IKr.69-71 This current is partially blocked by 10-6 mol/L zatebradine (Figs 6 and 7) . The small increase of APD observed at this rather high concentration of the drug is consistent with the IKr block (Fig 8) . In the whole SA node, a small APD increase was observed at these concentrations as well.30-32 At lower drug concentrations ( 10-7 mol/L), however, zatebradine causes a selective reduction of diastolic depolarization rate without a significant increase in APD or reduction in maximal diastolic potential.30 A small hyperpolarizing shift of the maximal diastolic depolarization was even observed in continuously paced whole SA node preparations.32 These data indicate that block of the delayed rectifier potassium current seems to be of little importance for the bradycardiac effect of the drug at concentrations used clinically. The tory period10 and QT. value23 also illustrates the absence of significant class III antiarrhythmic activity. A sodium-dependent background current, IbNa, seems to provide inward current during diastolic depolarization as well.72 Although no specific investigations into the effects of zatebradine on this current were performed, our data do not indicate a role of IbNa in the bradycardiac effect of the molecule, since no consistent reduction of the instantaneous current jump on hyperpolarization was observed (Figs 1, 3, and 7) .
Experiments performed at 32 to 340C (eg, Fig 7) indicate that the selectivity of zatebradine for If is present not only at room temperature (Figs 1, 2 , 5, and 6) but also at more physiological temperatures. At clinically used drug concentrations, the main effect of zatebradine on currents underlying diastolic depolarization in the SA node is, therefore, most likely usedependent blockade of If.
Clinical Implications Zatebradine belongs to a new class of drugs that act primarily through blockade of the pacemaker current If (or Ib). Since this mode of action allows selective heart rate reduction without direct effects on inotropism or atrioventricular conduction characteristics, these drugs can possibly provide the benefits of fl-adrenergic blocking drugs without causing some of their adverse effects.
Indeed, it has been demonstrated in animal experiments that the beneficial effect of cardioselective (3-blockers on exercise-induced ischemia is caused solely by the reduction of heart rate.",2 In states of high sympathetic stimulation, such as in angina pectoris, an increase in heart rate is realized (at least in part) by a shift of the If activation range to depolarized levels. By blocking If, zatebradine and related drugs can prevent the harmful effects of an increase of heart rate on myocardial oxygen balance. The frequency-dependent reduction of heart rate by zatebradine may provide a reduced chronotropic response to catecholamines without causing severe bradycardia at rest. In contrast to fl-blockers, no significant effect on blood pressure was observed with this drug, which will protect coronary perfusion.1014-17,24 In preliminary clinical trials, zatebradine has demonstrated antianginal activity.25,2728 More elaborate studies are required, however, to further describe its clinical effectiveness and safety.
Conclusions
The main electrophysiological effect of low concentrations of zatebradine on rabbit SA node is usedependent block of the pacemaker current If. Since If blockade occurs in the same concentration range as that causing heart rate reduction, it is probably responsible for the bradycardiac effect of the drug. Zatebradine, therefore, belongs to a new class of cardiac drugs. These "If blockers" offer selective reduction of heart rate without having the negative inotropic and dromotropic effects of l3-blockers. Drugs having this mode of action open new possibilities in cardiac therapy.
